Hedge Funds Get Boost From Healthcare In 2014VW Staff
The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotechnology Index has returned 18.35% so far this year, which beats the 3.74% return churned out by hedge funds across all strategies.
The shakedown of healthcare stocks provided hedge funds with a favorable entry point. Pharma . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible